Increased trading levels in GCM Resources (LON: GCM) have led to a doubling of the share price to 2.8p. Trading levels have not been this high for around one year. Share buying has also pushed up the share price of online building products retailer CMO Group (LON: CMO), which is asking for shareholder approval at […]

The post AIM weekly movers: Hornby leaving AIM appeared first on UK Investor Magazine.

North Sea oil and gas explorer Deltic Energy (LON: DELT) has revised its internal economic model for the development of the Selene project. This assumes first gas in 2029 at a production rate of 50mmcf/day and a post-tax NPV10 of $56m. The company is evaluating funding methods. The share price recovered 19.2% to 3.875p. Solid […]

The post AIM movers: Solid State wins contract and Synairgen set to leave junior market appeared first on UK Investor Magazine.

Cannabis-based medicines developer Celadon Pharmaceuticals (LON: CEL) says that the strategic collaboration with Valeos Pharma is contributing to its business. This will enable the acceleration of supply of pharmaceutical grade EU-GMP cannabis active pharmaceutical ingredient products. Valeos Pharma will provide up to three tonnes of annual cultivation capacity, which is equivalent to £8.7m of income/year. […]

The post AIM movers: Celadon Pharmaceuticals collaboration progress and Deltex Medical leaving AIM appeared first on UK Investor Magazine.

Goldstone Resources (LON: GRL) says it has agreed to assign the convertible loan notes to Devonport Capital and the redemption date has been extended to 31 January 2025. They will be converted into 85.9 million shares at 3.25p each – principal and interest will be £2.79m. This is reassuring for investors. The share price rose […]

The post AIM movers: Mitsubishi Electric invests in Seeing Machines and Gemfields suspends emerald production appeared first on UK Investor Magazine.

Active Energy Group (LON: AEG) shares returned from suspension following publication of interims and the potential for a resurrection of the business. Shareholders previously voted against liquidating the company and Zen Ventures provided a loan of £200,000 to enable the publication of 2023 accounts earlier in December and the subsequent interims have been released. Zen […]

The post AIM weekly movers: Potential resurrection for Active Energy appeared first on UK Investor Magazine.

Hostels operator Safestay (LON: SSTY) improved interim revenues by 7% to £10.7m and the loss reduced from £947,000 to £113,000. Sales to the end of August were well ahead of last year and forward bookings are strong into next year. The lease of the loss making Venna hostel has been surrendered. Four new properties have […]

The post AIM movers: Safestay recovery accelerates and delays hit Xeros Technology appeared first on UK Investor Magazine.

Mercantile Ports and Logistics (LON: MPL) has released 2023 figures slightly ahead of expectations. There was an impairment charge of £9.9m. The pre-tax loss fell from £12.1m to £11.4m. Debt restructuring discussions continue and this will firm up the financial position of the Indian port facility developer. An operating profit is forecast for 2024, but […]

The post AIM movers: Mercantile Ports debt restructuring talks continue and ex-dividends appeared first on UK Investor Magazine.

Ethernity Networks (LON: ENET) jumped 40.5% to 14.75p on the back of a new contract and the share price is above the level before the recent fall. An existing customer has awarded a follow-on contract worth $4.6m. Jarvis Securities (LON: JIM) has recovered a small proportion of its loss on Friday after it announced that […]

The post AIM movers: Ethernity Networks contract and Zoo upgrade appeared first on UK Investor Magazine.

GTCR LLC revealed it was considering a bid for GB Group (LON: GBG) after the market closed on Tuesday. The identification services provider says that it will evaluate any proposals it receives. There is no indication of possible terms or valuation. GTCR says that it is acting on behalf of certain affiliated funds. There is […]

The post AIM movers: GB Group bid approach and Arrow Exploration gas flow figures appeared first on UK Investor Magazine.

Synairgen shares plummeted 23.6% to 26.6p in late afternoon trading on Wednesday, after the company reported a research and development tax credit uptick to £9.2 million from £3.8 million, leading to a post-tax loss of £48.7 million in FY 2021 compared to £13.9 million in FY 2020. The pharmaceutical group announced a £57.9 million loss […]

The post Synairgen shares plummet on Covid-19 drug stumble appeared first on UK Investor Magazine.

The Synairgen share price was up 27.1% to 33.9p in late afternoon trading on Monday, after the biotech group presented the results of its Phase 3 SPRINTER trial for its SNG001 treatment at the American Thoracic Society (ATS) on Monday. The company reported that its SPRINTER trial failed to meet the primary endpoints of discharge […]

The post Synairgen presents Phase 3 SPRINTER trial data for ATS appeared first on UK Investor Magazine.

Synairgen shares have suffered a devastating year after the stock plummeted from 177p to 28p in just a few days in late February this year. The nasty disappointment followed the results of Synairgen’s SNG001 Covid-19 treatment, which failed to meet its primary and secondary efficacy endpoints in its Phase three SPRINTER late stage trial. The […]

The post Will the Synairgen share price ever recover? appeared first on UK Investor Magazine.

The Synairgen (LON:SNG) share price fell back to pre-Covid levels at one point on Monday following the disappointing phase III data for the SPRINTER trial for SNG001 use in hospitalised Covid-19 patients. The share price has recovered since then, but it has still lost four-fifths in one day. There is cash in the bank, but […]

The post Synairgen share price slumps by more than 80% appeared first on UK Investor Magazine.

Shares at British biotechnology firm Synairgen (LON:SNG) have surged more than 7% after the launch of its new large-scale Covid-19 treatment trial. The Southampton-based company treated its first patient at Hull Royal Infirmary on Tuesday afternoon, using the newly-developed formulation SNG001, which involves the inhalation of a naturally-occurring protein named interferon beta which is believed […]

The post Synairgen shares surge on trial launch appeared first on UK Investor Magazine.

Respiratory drug developers, Synairgen (AIM:SNG), saw their shares rally by almost a third on Friday, as the company reports that its SG016 trial demonstrated the efficacy of its SNG001 treatment in treating patients with COVID-19. The company posted its recent trial data in The Lancet Respiratory Medicine journal, which illustrated ‘positive topline results’ from a […]

The post Synairgen shares bounce 30% as SNG001 shown to accelerate COVID-19 recovery appeared first on UK Investor Magazine.

The FTSE 100 index (INDEXFTSE:UKX) opened on a sour note on Monday morning, sinking to a low of 6225.11 points at BST 08:25 on the back of slow progress at the EU rescue deal summit and ongoing tensions between the UK and China over Hong Kong and allegations of abuse against Uighur Muslims. EU nations […]

The post Sour start for FTSE 100 amid brewing UK-China tensions appeared first on UK Investor Magazine.